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Objective. This report responds to a request from a deputy editor of the
Journal of Ultrasound in Medicine (JUM) for guidelines for measurement and
reporting of acoustic output and exposure. The request was addressed to the
American Institute of Ultrasound in Medicine’s Technical Standards and
Bioeffects Committees, which appointed a task group to draft a response. A
basic premise of scientific reporting is the expectation that another investi-
gator will wish to replicate a reported study. Therefore, it is essential that all
pertinent information available or accessible to an investigator be reported.
Methods and Guidelines. Rationales and checklists are presented to draw
authors’ attention to aspects of experimental design and exposimetry that
require consideration in project planning, execution, and reporting.
Checklists are presented for use in 2 distinct categories of activity: (1) clinical
settings in which a biophysical end point (bioeffect) is observed incidentally
during another procedure; and (2) research projects specifically planned to
investigate biophysical end points (bioeffects). Reportable parameters for the
former are limited to essentials, whereas those for the latter are presented in
detail. Certain basic information is recommended as mandatory for reports
in both categories; certain additional parameters are designated as expected
(at 3 levels of importance) when results of research are reported. Clinical
investigators should comply with the short, first table (Table 1) and the last
(Table 5) if applicable, but are encouraged to include additional data speci-
fied in other tables, as appropriate. Bioeffects experimenters should comply
with Table 2 and such supplementary tables as are applicable to their study
design. Table 3 is applicable if the study involved animal or human subjects.
Table 4 is applicable if the study was on cells or in vitro. Table 5 is applicable
if contrast agents were used in the study. Conclusions. We recommend that
principal authors be required to certify to the JUM editors that they have
reviewed the appropriate checklists and complied with indicated expecta-
tions. We recommend to reviewers that they consider individually adopting
a mandatory requirement for reporting a basic set of parameters and/or
descriptors of the equipment that are readily ascertainable by, or should be
known to, a clinical user. Key words: acoustic output; authors; bioeffects;
exposure guidelines; measurement; reviewers; reporting.
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Special Report
he editors of the Journal of Ultrasound in
Medicine (JUM) are concerned about the
frequent need heretofore to revise sub-
mitted manuscripts reporting bioeffects
to amplify the description of exposure methods
and dosimetry. Therefore, this report presents
rationales and checklists to draw authors’ atten-
tion to aspects of experimental design and
exposimetry that require consideration in project
planning, execution, and reporting.
Checklists are presented for use in 2 distinct
categories of activity: 
1. Clinical settings in which a biophysical end
point (bioeffect) is observed incidentally dur-
ing another procedure; and 
2. Research projects specifically planned to
investigate biophysical end points (bioef-
fects).
Reportable parameters for the former are limit-
ed to essentials, whereas those for the latter are
presented in as exhaustive detail as the writers
could conceive. Certain elementary parameters,
such as the identity of the ultrasonic equipment
used, are recommended as mandatory for reports
in both categories; certain additional parameters
are designated as expected (at 3 levels of impor-
tance) when results of research are reported.
For an introduction to the subject, we recom-
mend perusal of Ziskin and Lewin’s Ultrasonic
Exposimetry,1 particularly Chapters 1, 2 (Parts II
and III), 3 (Part II), 4, 11 (Parts II and III), 12, and
13. Chapter 5 delves into methods of measuring
acoustic power and acoustic pressure. Although
this book is out of print, it is available from
some libraries (a useful website for checking
holdings worldwide is www.librarytechnology.
org/libwebcats).
In 1998 and 2003, the American Institute of
Ultrasound in Medicine (AIUM) and the National
Electrical Manufacturers Association (NEMA)
jointly published editions of Acoustic Output
Measurement Standard for Diagnostic Ultrasound
Equipment.2 This is a complex document, which
rigorously addresses most aspects of acoustic out-
put measurement and traceability to international
reference standards. It is suitable for those required
or willing to make a considerable investment in
equipment and staff for frequent measurements,
for example, some research laboratories, test hous-
es, manufacturers, and regulators.
Clinical users face somewhat different situations
than bioeffects investigators. On the one hand,
manufacturers must provide information about the
acoustic outputs of their equipment in a form that is
useful in the day-to-day clinical practice of the
entire diagnostic ultrasound community. The ther-
mal index (TI) and mechanical index (MI)3 were
devised and are commonly displayed on screen to
give the user a simple and rapid, but crude, estimate
of relative acoustic output of their equipment. On
the other hand, bioeffects investigators use the slow
process of publication to communicate to the much
smaller research community the actual exposures
experienced by the subjects of their experiments. In
research, greater accuracy is not only achievable but
also is more important than in day-to-day clinical
activity. Furthermore, the investigator’s report to
peers in the research community may use different
language and should supply greater detail than a
manufacturer provides to its customers.
In principle, every experiment presents unique
problems of ultrasonic dosimetry. Most bioeffects
studies, however, fall into 1 of 3 broad categories:
1. Animal studies, which have yielded most
bioeffects information that is directly useful; 
2. Observations of effects of ultrasound on cell
preparations, which have yielded some basic
knowledge; and 
3. Pertinent clinical studies, including all our
epidemiologic data on the use of diagnostic
ultrasound. 
As categories of research, each has its own
dosimetry characteristics. 
Animal Studies
The parameters of primary interest in a bioef-
fects study are usually a temperature rise and
pressure amplitude at the specimen. These
parameters have been related, respectively, to
thermal and mechanical mechanisms, the two
major, established effects of ultrasound in bio-
logical tissues. In principle, it should be possible
to compute the temperature elevation from a
complete knowledge of the acoustic and thermal
parameters of the source and target. However,
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this process is so challenging that a direct mea-
surement of temperature is preferable even if it
is difficult. Thermocouples may be threaded
through tissue to record temperature rise
directly. Thermocouple measurements during
ultrasound exposure are subject to artifacts
from viscous heating at the tissue-wire inter-
face. Errors in determination of true mam-
malian tissue temperature that are introduced
in this way are usually minimal if the thermo-
couple is small (<50 µm diameter) and the
exposure times are long (>1 minute).
Even when the mechanism of action is
assumed to be thermal, the acoustic pressures
at the site of interest in the animal as well as the
physical parameters needed to compute tem-
perature rise should be reported. The former is
normally accomplished by a hydrophone mea-
surement of the free-field, peak-positive and 
-negative pressures (in megapascals) at the
position to be occupied by the animal and then
by estimating the actual pressures in the ani-
mal, using corrections for attenuation of the
ultrasound field by the overlying tissue.
Parameters reported for the latter should
include distance  between transducer and spec-
imen or point of interest, pulsing conditions
(mode, pulse repetition frequency, duty cycle,
and frame rate), beam profile (–6 and –12 dB
beam diameter in azimuthal and elevational
directions at the depth of interest, if known, or
elevational, focal depth), measured center 
frequency, bandwidth, and spatial-peak, temporal-
average intensity. The same acoustic parame-
ters should be reported for experiments in
which the mechanism of action of ultrasound is
assumed to be nonthermal.
In general, but particularly when the temporal-
peak pressures are large and the waveforms are
distorted by nonlinear propagation, it is useful to
provide a pressure-time plot of the pulse profile
at the site to be occupied by the experimental
animal.
Justification for ignoring heating in these
experiments can frequently be given analytical-
ly by reference to the measured, acoustic inten-
sity and exposure time.4 In borderline cases,
however, direct, thermocouple measurements
may be necessary to demonstrate that heating
is negligible.
Cell Suspensions
The bioeffects literature is replete with reports
of the effects resulting from ultrasonic expo-
sures of suspensions of cells. From the stand-
point of dosimetry, there is a fundamental
difference between these exposures and those
experienced by the tissues of experimental ani-
mals. In animal experiments, the beam pattern
of the ultrasound field conveys the information
about the distribution of exposure to different
parts of the tissue. Cell suspensions, in contrast,
are continuously stirred during exposure by
acoustic streaming. Also, standing waves may
be produced in the exposure vessel, and the dis-
tribution of cells in the exposure vessel may be
affected by the standing waves. Standing waves
introduce large gradients in the field to which
the suspended cells are actually exposed. These
may change the distribution of cells and bub-
bles in the medium, which in turn may influ-
ence the biological effect. Therefore, in addition
to the acoustic parameters recommended for
animal experiments, reports of experiments
with cell suspensions should contain informa-
tion about the exposure vessel and estimates of
the temporal characteristics of the sound field
that the cells experienced. A comprehensive
review of exposure systems as well as in vitro
bioeffects of inertial cavitation is provided by
Miller et al.5
A Note on the Ultrasound Indices
Thermal and mechanical indices are descrip-
tors of the output of diagnostic ultrasound
systems and are defined in the AIUM/NEMA
Output Display Standard (ODS).3 In general,
they are not appropriate indicators for report-
ing the acoustic exposure in a bioeffects
experiment. In contrast to the simple num-
bers that describe exposure, the definitions of
the indices are complicated and involve
mathematical models and assumptions about
the propagating media. They differ qualita-
tively from the acoustic exposure parameters
needed to describe exposures in bioeffects
experiments.
The importance of the TI and MI is to allow the
operator to compare relative values of these
indices under different operating conditions
selected in the course of an imaging session.
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The TI, for example, is a rough estimate of the
maximum temperature increment in the field of
an ultrasound source, assuming that the trans-
ducer is in contact with a medium whose prop-
erties are those that are built into the definition
of the TI through the assumed model. The loca-
tion of the temperature maximum in the ultra-
sound field is not known from the value of the TI,
nor is the actual temperature rise anywhere in a
specific tissue medium. For example, if the actu-
al temperature rise at the site of interest in an
animal experiment is 1°C and the actual maxi-
mum temperature rise elsewhere in the field is
3°C but the TI formula yields an estimate of 5,
the thermal exposure is 1°C but the displayed TI
would be 5. If the transducer is then removed
from the tissue and without other change radi-
ates into a water medium, temperature rises in
the water would be minimal everywhere but the
TI would still be 5, because the TI is a descriptor
of the ultrasound system coupled to the specified
tissue-equivalent medium, not an estimate of the
maximum temperature rise in a different medi-
um (ie, water). Thus, the TI is irrelevant to exper-
iments conducted in aqueous media.
A similar rationale applies to the MI. It describes
certain acoustic properties of the source, but it is
not a basic exposure parameter. The use of the MI
as an exposure parameter in several published
reports has led to confusion and errors in the
description of subject exposure.
These facts in no way denigrate the output
indices. Their incorporation in standards and
their display on the screens of diagnostic ultra-
sound systems are as important to ultrasound
safety as basic bioeffects research. The output
information they supply is limited in quantity and
quality, but it comes in a form that is suitable and
the best available for the concerned clinical user
to make use of existing bioeffects knowledge.
Clinical Studies
At a minimum, the acoustic output of clinical
equipment to be used for a bioeffects study
should be measured before and spot-checked
after the study, preferably by or with the assis-
tance of its manufacturer using AIUM/NEMA or
International Electrotechnical Commission
(IEC) standard methods. Researchers are encour-
aged to seek assistance of the manufacturer or a
qualified testing program. If test conditions were
changed during the study, then recalibration
would be necessary after the study.
Results will depend on the particular trans-
ducer assembly and equipment settings used.
(Note: Acoustic output data provided in manu-
als supplied with ultrasound diagnostic equip-
ment may not be relevant because of the many
possible combinations of equipment settings
and because transducer-to-transducer varia-
tions and, to a lesser degree, system-to-system
variations can be substantial.) Results of these
calibrations, specifying the test methods and
equipment settings used in the study, should be
reported in a manuscript. Notable disadvan-
tages of this recommended calibration proce-
dure are loss of the use of clinical equipment
while it is being calibrated and associated
transportation and test costs. To minimize
these disadvantages, it may be considered ade-
quate if only the investigator’s transducer
assembly is calibrated and assurance is given
that the equipment console has been main-
tained to the manufacturer’s performance spec-
ifications. In all cases, essential calibration
entails prediction of the ranges of equipment set-
tings that will be used in the study.
Clinical investigators fortunate enough to have
biophysicists or biomedical engineers in-house
may be able to expedite calibrations by making
use of existing facilities. At a minimum, a stan-
dard, calibrated hydrophone and an instrument-
ed testing tank are needed for such calibrations.
An acoustic (radiation) force balance is desirable
but not essential.
Reporting calibrated, acoustic output power is
only the first step. Exposure refers to acoustic
conditions at the specimen remote from the
transducer assembly. Ultrasound propagated
from the transducer assembly may be diffracted,
focused, absorbed, scattered, reflected, refract-
ed, or converted to a different frequency or
propagation mode before it reaches the speci-
men. Ideally, the acoustic properties of all media
intervening between the transducer assembly
and the specimen will be reported to permit cal-
culations, if desired. Practically, it is recognized
that in some cases sufficient data may not be
available. Nevertheless, due diligence should be
exercised to report as comprehensively as possi-
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ble. In the accompanying tables, parameters
that are expected to be reported are ranked in
importance.
With human subjects, direct measurement of
temperature rises and acoustic pressures in situ
are normally precluded. In these experiments,
the on-screen values of TI and MI may be
reported, but doing so does not relieve the
investigators of the responsibility of computing
the actual exposure data at the sites presumed to
be affected by ultrasound exposure and report-
ing those values and the methods used in deter-
mining them.
Discussion and Recommendations
In all studies, the overarching purpose of
reporting exposure parameters is to enable
other investigators to replicate studies and
thereby validate, supplement, or call in ques-
tion published results. Reviewers bearing this
purpose in mind may hold different opinions
on what is necessary and sufficient to ensure
replicability.
Authors may have complied with standards
that specify precise methods for making ultra-
sound field measurements, or they may have
relied on documentation or cited reports; in
all cases, they are expected to report their
sources and results. It is important for authors
to review a checklist of factors that identify the
equipment and determine the exposure to
ensure that all expected or available data are
included in a manuscript. However, as noted
above, parameters important for one type of
study may be unimportant for another type.
The following checklists (Tables 1–5) are pro-
vided in tabular form to encourage reporting of
information that reviewers will need to evaluate
manuscripts and other investigators will need
to replicate experiments or perform supple-
mentary calculations.
Clinical investigators should comply with the
short, first table (Table 1) and the last (Table 5),
if applicable, but are encouraged to include
additional data specified in other tables, as
appropriate.
Bioeffects experimenters should comply
with Table 2 and such supplementary tables as
are applicable to their study design. Table 3 is
applicable if the study involved animal or
human subjects. Table 4 is applicable if the
study was on cells or in vitro. Table 5 is appli-
cable if contrast agents were used in the study.
We recommend that principal authors be
required to certify to the JUM editors that they
have reviewed the appropriate checklists and
complied with indicated expectations.
Definitions of terms are provided in the AIUM’s
Recommended Ultrasound Terminology.6
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Table 1. Checklist for Reporting OBSERVATIONS Involving Ultrasound Exposures of HUMAN SUBJECTS
Machine Parameters Recommendation Unit Notes
Manufacturer MR
Console model MR Part number, serial number
Transducer model MR Style, part number, serial number
Software version number MR
Scanning mode and submode MR eg, B-mode, compounded, harmonic
Focusing MR Geometrical or electronic, static or dynamic
Focal range MR mm
Machine settings MR Application type (eg, general, Ob, cardiac) and
eg, selected center frequency, velocity scale,
frame rate, sector size, displayed acoustic
output %, sampling gate size (in spectral Doppler)
Displayed MI MR Per ODS, MI is defined only at the position of
maximum pulse intensity integral (derated)
Displayed TI MR
Time of exposure MR min
MI indicates mechanical index; MR, mandatory reporting recommended; Ob, obstetric; and TI, thermal index.
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Table 2. Checklist for Reporting EXPERIMENTS Involving Ultrasound Exposures (ALL STUDIES)
Parameters Recommendation Unit Notes
Machine parameters
Manufacturer MR
Console model MR Part number, serial number
Transducer model MR Style, part number, serial number
Software version number MR
Scanning mode and submode MR eg, B-mode, compounded, harmonic
Machine settings MR Application type (eg, general, Ob, cardiac) and
eg, selected center frequency, velocity scale,
frame rate, sector size, displayed acoustic out-
put %, sampling gate size (in spectral Doppler)
Displayed MI +++ Per ODS, MI is defined only at the position of
the maximum pulse intensity integral (derated)
Displayed TI +++
Calibration methods
Standards invoked or traceability (MR) eg, following AIUM 1998 measurement standard
or other
Transducer parameters
Transducer type +++ eg, single disk, circular array, liner array, multiunit
rotating, immersed
Transducer aperture shape eg, circular, rectangular
Transducer aperture dimensions +++ mm eg, physical diameter, height and width of the
active elements
Number of elements
Size of elements mm Length, width, and pitch
Beam pattern Show figure
Beam cross-sectional profile or (+++) mm All at depth of interest or elevational, focal depth
azimuthal and elevational beam 
widths eg, Gaussian, Bessel
If widths, –3, –6, and –12 dB
Focusing +++ Geometric or electronic, static or dynamic
F-number(s) (or active dimensions)
Focal length +++ mm Depth of (PII.0 max), if measurements are made;
nominal values, if measurements are not made
Depth of focus (focal zone depth ++ mm eg, 50–130 mm
range)
Side lobes (dB down) (++) dB Report as a negative number, eg, –30 dB
Grating lobes (++) dB Report as a negative number, eg, –30 dB
Exposure parameters
Acoustic power output at (+++) mW Report estimated accuracy of acoustic power
transducer (Wo) measurement
Mode of operation +++ Pulse or continuous wave
Pulse center frequency +++ MHz Nominal values, if measurements are not made
Pulse echo-response profile eg, damped single cycle, continuous wave burst
(show figure)
Pulse duration +++ µsec Per standards if measured; nominal values, if
measurements are not made
Duty factor %
Pulse repetition frequency +++ Hz If pulsed Doppler or color mode; nominal values, if
measurements are not made
Frame rate +++ Hz If B-mode or color mode; nominal values, if meas-
urements are not made
(continued)
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Table 2. (continued) Checklist for Reporting EXPERIMENTS Involving Ultrasound Exposures (ALL STUDIES)
Parameters Recommendation Unit Notes
Exposure parameters (continued)
Nonderated intensity at specimen (+++) W/cm2, Measured in water
(ISPTP, ISPTA, ISATA) mW/cm
2
Estimated attenuated intensity (+++) W/cm2, Report attenuation coefficient α used in estimation
and power at specimen mW/cm2, 
(ISPTP,α, ISPTA,α, ISATA,α, W.3[z]) W
Peak rarefactional pressure at (+++) MPa Measured in water
specimen (nonderated)
Estimated attenuated peak (+++) MPa Report attenuation coefficient used in estimation
rarefactional pressure at specimen
Peak compressional pressure at (+++) MPa Measured in water
specimen (nonderated)
Estimated attenuated peak compress- (+++) MPa Report attenuation coefficient used in estimation
ional pressure at specimen
Measurement equipment used
Acoustic power equipment and ++ eg, radiation force balance, hydrophone raster
method scan, . . .
Hydrophone and amplifier ++ Which hydrophone and amplifier model and S/N
used? When calibrated?
Digitizer + Manufacturer, model, number of bits resolution
Positioning system + eg, stepper motors, hand crank
Water temperature +++ °C
Exposure tank dimensions cm or m
Exposure tank volume L Filled volume
Exposure tank wall absorbers Manufacturer, description
Exposure tank reflection coefficient dB Report as a negative number (dB down), eg, –20 dB
Medium degassing method (if water) Report if water deionized, distilled, or from tap 
Regassing precautions eg, floating polystyrene balls
Experimental parameters and conditions
Range from transducer to target or MR cm
specimen (z)
Acoustic coupling medium eg, gel, gel pad, degassed water
Intervening media types ++ eg, fat, muscle, bone, amniotic fluid
Intervening media thicknesses ++ mm
Intervening media boundary 
geometry
Intervening media speeds of sound + m/s
Intervening media acoustic impedances + Mrayl rayl = kg ⋅ m–2 ⋅ s–1
Intervening media acoustic attenuation + dB ⋅ cm–1 ⋅
coefficients MHz–1
Error analysis
Probable random errors +++ Or type A
Probable systematic errors +++ Or type B
Supporting material
Line drawing of experimental 
apparatus with dimensions
Photograph of exposure in progress
ISATA indicates spatial-average, temporal-average intensity; ISPTA, spatial-peak, temporal-average intensity; ISPTP, spatial-peak, tem-
poral peak intensity; α, attenuation coefficient assumed in calculations for the acoustic path between the transducer and the
specimen;  MR, mandatory reporting recommended; Ob, obstetric; PII.0, pulse intensity integral (nonderated); S/N, signal/noise
ratio; and W.3[z], estimated attenuated power at specimen. Data reports: +++ indicates definitely expected; ++, highly expect-
ed; +, expected; and (. . .), report data if measurements are made per ODS or other cited standard; otherwise, report is optional.
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Table 3. SUPPLEMENTAL Checklist for Reporting EXPERIMENTS Involving Ultrasound Exposures (ANIMAL
and HUMAN STUDIES)
Parameters Recommendation Unit Notes
Skin shaved and depilated +++ Proximally/distally
Distal acoustic impedance mismatch ++ Mrayl eg, air, foam, fluid, fur? rayl = kg ⋅ m–2 ⋅ s–1
Tissue temperature as function of time (++) °C(s) Measured or estimated
Measurement protocol +++ Describe in text
Skin temperature under transducer °C
assembly
Actual or average tissue types ++
Tissue thicknesses mm Between transducer and focal region
Tissue boundary geometry in beam 
path
Tissue speed of sound m/s
Tissue attenuation coefficient dB ⋅ cm–1 ⋅
MHz–1
Data reports: +++ indicates definitely expected; ++, highly expected; and (. . .), report data if measurements are made per
ODS or other cited standard; otherwise, report is optional.
Table 4. SUPPLEMENTAL Checklist for Reporting EXPERIMENTS Involving Ultrasound Exposures (CELL or
IN VITRO STUDIES)
Parameters Recommendation Unit Notes
Chamber
Chamber shape +++
Chamber dimensions +++ mm
Chamber commercial origin Manufacturer’s part number
Construction materials Describe in text
Construction materials (density) g/cm3
Construction materials (speed of m/s
sound)
Chamber rotation speed +++ rpm If applicable
Chamber standing wave Describe in text
assessment
Suspending medium
Suspending medium speed of sound +++ m/s
Suspending medium temperature +++ °C
Suspending medium viscosity + g ⋅ cm–1 ⋅ s–1
Suspending medium air/gas interface +++ Describe and quantify in text
Suspending medium depth or volume +++ mm or mL
Suspending medium density +++ g/cm3
Data reports: +++ indicates definitely expected; and +, expected.
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A feature of the tables is the ranking of parame-
ters as “expected” (+), “highly expected” (++), and
“definitely expected” (+++) to be reported.
Rankings are based on an assessment of the
value of the data to other researchers and the
ease or difficulty of their determination. Data for
all other, unranked parameters are nonetheless
desirable. 
Another feature is the term mandatory report-
ing (MR). 
We recommend to reviewers that they consider
individually adopting a mandatory requirement
for reporting a basic set of parameters and/or
descriptors of the equipment that are readily
ascertainable by, or should be known to, a clinical
user. The final decision rests with the editors, of
course.
In justification of such extensive detail, we
reiterate that a basic aspect of scientific
reporting is the expectation that another
investigator will wish to replicate a reported
study. Therefore, it is essential for all pertinent
information that is available or accessible to
an investigator be reported. Our minimum
goal is to avoid inadvertent omission of avail-
able or accessible information. Beyond that,
we hope to stimulate investigators to give ade-
quate consideration to the acoustic aspects of
their experimental design and reviewers of
their manuscripts to apply consistent criteria
to the reports that they are evaluating for pub-
lication.
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Table 5. SUPPLEMENTAL Checklist for Reporting EXPERIMENTS Involving Ultrasound Exposures 
(CONTRAST AGENT STUDIES)
Parameters Recommendation Unit Notes
Manufacturer +++
Type +++ Trade name
Composition +++ Capsule material and encapsulated gas
or liquid
Total quantity of injected agent +++ mm3
Concentration of injected agent +++ #/mm3, 
Use protocol +++ mm3/kg Describe in text, eg, injection as bolus,
speed of injection
Liquid handling protocol +++ From reservoir to heart; describe in text,
eg, degassing method, residual gas
(O2) content
Data reports: +++ indicates definitely expected.
